Kumar A - Search Results

1

Universal Access to Xpert MTB/RIF Testing for Diagnosis of Tuberculosis in Uzbekistan: How Well Are We Doing?

Turaev L, Kumar A, Nabirova D, Alaverdyan S, Parpieva N, Abdusamatova B. Turaev L, et al. Among authors: kumar a. Int J Environ Res Public Health. 2021 Mar 12;18(6):2915. doi: 10.3390/ijerph18062915. Int J Environ Res Public Health. 2021. PMID: 33809168 Free PMC article.

2

LED-fluorescence microscopy for diagnosis of pulmonary tuberculosis under programmatic conditions in India.

Reza LW, Satyanarayna S, Enarson DA, Kumar AM, Sagili K, Kumar S, Prabhakar LA, Devendrappa NM, Pandey A, Wilson N, Chadha S, Thapa B, Sachdeva KS, Kohli MP. Reza LW, et al. Among authors: kumar s, kumar am. PLoS One. 2013 Oct 9;8(10):e75566. doi: 10.1371/journal.pone.0075566. eCollection 2013. PLoS One. 2013. PMID: 24130719 Free PMC article.

3

Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?

Dave P, Vadera B, Kumar AM, Chinnakali P, Modi B, Solanki R, Patel P, Patel P, Pujara K, Nimavat P, Shah A, Bharaswadkar S, Rade K, Parmar M, Nair SA. Dave P, et al. Among authors: kumar am. PLoS One. 2015 Apr 13;10(4):e0121996. doi: 10.1371/journal.pone.0121996. eCollection 2015. PLoS One. 2015. PMID: 25874545 Free PMC article.

4

Extending 'Contact Tracing' into the Community within a 50-Metre Radius of an Index Tuberculosis Patient Using Xpert MTB/RIF in Urban, Pakistan: Did It Increase Case Detection?

Fatima R, Qadeer E, Yaqoob A, Haq MU, Majumdar SS, Shewade HD, Stevens R, Creswell J, Mahmood N, Kumar AM. Fatima R, et al. Among authors: kumar am. PLoS One. 2016 Nov 29;11(11):e0165813. doi: 10.1371/journal.pone.0165813. eCollection 2016. PLoS One. 2016. PMID: 27898665 Free PMC article.

5

High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India.

Shewade HD, Kokane AM, Singh AR, Verma M, Parmar M, Chauhan A, Chahar SS, Tiwari M, Khan SN, Gupta V, Tripathy JP, Nagar M, Singh SK, Mehra PK, Kumar AM. Shewade HD, et al. Among authors: kumar am. BMC Health Serv Res. 2017 Apr 4;17(1):249. doi: 10.1186/s12913-017-2191-6. BMC Health Serv Res. 2017. PMID: 28376789 Free PMC article.

6

How has the Zimbabwe mycobacterial culture and drug sensitivity testing system among re-treatment tuberculosis patients functioned during the scale-up of the Xpert MTB/RIF assay?

Timire C, Takarinda KC, Harries AD, Mutunzi H, Manyame-Murwira B, Kumar AMV, Sandy C. Timire C, et al. Trans R Soc Trop Med Hyg. 2018 Jun 1;112(6):285-293. doi: 10.1093/trstmh/try054. Trans R Soc Trop Med Hyg. 2018. PMID: 29992299 Free PMC article.

7

Access to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain^{^®} Line Probe Assay in Southern provinces, Zimbabwe.

Timire C, Sandy C, Kumar AMV, Ngwenya M, Murwira B, Takarinda KC, Harries AD. Timire C, et al. Int J Infect Dis. 2019 Apr;81:236-243. doi: 10.1016/j.ijid.2019.02.007. Epub 2019 Feb 15. Int J Infect Dis. 2019. PMID: 30776546 Free article.

8

HIV care among patients with presumptive tuberculosis in Masvingo district of Zimbabwe, 2017: how well are we doing?

Ndudzo C, Tripathy JP, Tauro F, Sibanda C, Chiramba M, Shamu A, Masinire K, Muchengwa T, Kumar AM. Ndudzo C, et al. Among authors: kumar am. Pan Afr Med J. 2019 Jul 3;33:158. doi: 10.11604/pamj.2019.33.158.15847. eCollection 2019. Pan Afr Med J. 2019. PMID: 31565120 Free PMC article.

9

Implementation of the new integrated algorithm for diagnosis of drug-resistant tuberculosis in Karnataka State, India: How well are we doing?

Shankar S U, Kumar AMV, Venkateshmurthy NS, Nair D, Kingsbury R, R P, Velu M, P S, Gupta J, Ahmed J, G P, Hiremath S, Jaiswal RK, Kokkad RJ, N S. Shankar S U, et al. PLoS One. 2021 Jan 6;16(1):e0244785. doi: 10.1371/journal.pone.0244785. eCollection 2021. PLoS One. 2021. PMID: 33406153 Free PMC article.

10

Extending contact screening within a 50-m radius of an index tuberculosis patient using Xpert MTB/RIF in urban Pakistan: Did it impact treatment outcomes?

Ul Haq M, Hinderaker SG, Fatima R, Shewade HD, Heldal E, Latif A, Kumar AMV. Ul Haq M, et al. Among authors: kumar amv. Int J Infect Dis. 2021 Mar;104:634-640. doi: 10.1016/j.ijid.2021.01.054. Epub 2021 Jan 27. Int J Infect Dis. 2021. PMID: 33515773 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30,293 results

Search Page